Skip to main content
. 2001 Jul;159(1):297–304. doi: 10.1016/S0002-9440(10)61695-1

Table 3.

Five-Year Cumulative Probability for Survival and Relapse According to the Number of CD3+, CD8+, and GrB+ IELs Stratified Using Median Value as Cut-Point

5 Year cumulative probability (95% CI) Log-rank test chi-square (P value) HR* (95% CI)
Below median Above median
CD3+ IELs
Survival
Stage
II 0.77 (0.60–0.95) 0.87 (0.76–0.99) 1.04 (0.3) 0.50 (0.13–1.94)
III 0.39 (0.21–0.57) 0.70 (0.49–0.90) 4.79 (0.03) 0.37 (0.14–0.93)
Overall 0.55 (0.42–0.69) 0.80 (0.70–0.91) 8.22 (0.004) 0.40 (0.19–0.85)
Relapse
Stage
II 0.77 (0.60–0.95) 0.91 (0.80–1.00) 1.73 (0.2) 0.40 (0.09–1.76)
III 0.42 (0.22–0.61) 0.65 (0.44–0.86) 2.96 (0.09) 0.45 (0.18–1.11)
Overall 0.58 (0.44–0.72) 0.80 (0.70–0.91) 6.48 (0.01) 0.42 (0.19–0.92)
CD8+ IELs
Survival
Stage
II 0.64 (0.44–0.84) 0.94 (0.91–1.00) 8.07 (0.005) 0.14 (0.03–0.65)
III 0.44 (0.26–0.62) 0.63 (0.42–0.85) 2.10 (0.1) 0.50 (0.20–1.22)
Overall 0.52 (0.39–0.66) 0.82 (0.72–0.93) 11.16 (0.0008) 0.33 (0.15–0.73)
Relapse
Stage
II 0.68 (0.48–0.88) 0.94 (0.86–1.00) 6.52 (0.01) 0.17 (0.04–0.83)
III 0.42 (0.23–0.62) 0.64 (0.43–0.86) 1.71 (0.2) 0.47 (0.19–1.17)
Overall 0.54 (0.40–0.68) 0.83 (0.73–0.93) 9.55 (0.002) 0.35 (0.16–0.78)
GrB+ IELs
Survival
Stage
II 0.64 (0.45–0.83) 0.96 (0.90–1.00) 9.48 (0.002) 0.07 (0.01–0.53)
III 0.29 (0.12–0.46) 0.72 (0.54–0.90) 7.52 (0.006) 0.32 (0.14–0.77)
Overall 0.46 (0.32–0.59) 0.85 (0.76–0.95) 17.48 (0.0001) 0.23 (0.10–0.50)
Relapse
Stage
II 0.64 (0.44–0.83) 1.00 (1.00–1.00) 12.73 (0.0004)
III 0.28 (0.10–0.46) 0.72 (0.54–0.89) 7.12 (0.008) 0.33 (0.14–0.79)
Overall 0.46 (0.32–0.60) 0.87 (0.78–0.96) 18.71 (0.0001) 0.20 (0.09–0.46)

*Estimates from separate proportional hazard regression models including terms for sex, age, and stage as appropriate. Reference category was represented by cases below the median value.

†No events.